298 related articles for article (PubMed ID: 1698290)
1. PD134308, a selective antagonist of cholecystokinin type B receptor, enhances the analgesic effect of morphine and synergistically interacts with intrathecal galanin to depress spinal nociceptive reflexes.
Wiesenfeld-Hallin Z; Xu XJ; Hughes J; Horwell DC; Hökfelt T
Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7105-9. PubMed ID: 1698290
[TBL] [Abstract][Full Text] [Related]
2. Studies on the effect of systemic PD134308 (CAM 958) in spinal reflex and pain models with special reference to interaction with morphine and intrathecal galanin.
Wiesenfeld-Hallin Z; Xu XJ; Hughes J; Horwell DC; Hökfelt T
Neuropeptides; 1991 Jul; 19 Suppl():79-84. PubMed ID: 1715529
[TBL] [Abstract][Full Text] [Related]
3. Intrathecal galanin potentiates the spinal analgesic effect of morphine: electrophysiological and behavioural studies.
Wiesenfeld-Hallin Z; Xu XJ; Villar MJ; Hökfelt T
Neurosci Lett; 1990 Feb; 109(1-2):217-21. PubMed ID: 1690366
[TBL] [Abstract][Full Text] [Related]
4. Neither cholecystokinin nor galanin modulate intrathecal clonidine-induced depression of the nociceptive flexor reflex in the rat.
Xu XJ; Wiesenfeld-Hallin Z
Brain Res; 1993 Sep; 621(2):267-71. PubMed ID: 7694763
[TBL] [Abstract][Full Text] [Related]
5. The CCK-B antagonist CI988 enhances the reflex-depressive effect of morphine in axotomized rats.
Xu XJ; Hökfelt T; Hughes J; Wiesenfeld-Hallin Z
Neuroreport; 1994 Feb; 5(6):718-20. PubMed ID: 8199346
[TBL] [Abstract][Full Text] [Related]
6. Increased spinal cholecystokinin activity after systemic resiniferatoxin: electrophysiological and in situ hybridization studies.
Broberger C; Farkas-Szallasi T; Szallasi A; Lundberg JM; Hökfelt T; Wiesenfeld-Hallin Z; Xu XJ
Pain; 2000 Jan; 84(1):21-28. PubMed ID: 10601669
[TBL] [Abstract][Full Text] [Related]
7. CI 988, an antagonist of the cholecystokinin-B receptor, potentiates endogenous opioid-mediated antinociception at spinal level.
Xu XJ; Elfvin A; Hao JX; Fournié-Zaluski MC; Roques BP; Wiesenfeld-Hallin Z
Neuropeptides; 1997 Jun; 31(3):287-91. PubMed ID: 9243527
[TBL] [Abstract][Full Text] [Related]
8. Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity.
Hughes J; Boden P; Costall B; Domeney A; Kelly E; Horwell DC; Hunter JC; Pinnock RD; Woodruff GN
Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6728-32. PubMed ID: 1975695
[TBL] [Abstract][Full Text] [Related]
9. Cholecystokinin B antagonists strongly potentiate antinociception mediated by endogenous enkephalins.
Valverde O; Maldonado R; Fournie-Zaluski MC; Roques BP
J Pharmacol Exp Ther; 1994 Jul; 270(1):77-88. PubMed ID: 8035345
[TBL] [Abstract][Full Text] [Related]
10. Differential modulation of alpha 2-adrenergic and opioid spinal antinociception by cholecystokinin and cholecystokinin antagonists in the rat dorsal horn: an electrophysiological study.
Sullivan AF; Hewett K; Dickenson AH
Brain Res; 1994 Oct; 662(1-2):141-7. PubMed ID: 7859067
[TBL] [Abstract][Full Text] [Related]
11. Intrathecal cholecystokinin interacts with morphine but not substance P in modulating the nociceptive flexion reflex in the rat.
Wiesenfeld-Hallin Z; Duranti R
Peptides; 1987; 8(1):153-8. PubMed ID: 2437547
[TBL] [Abstract][Full Text] [Related]
12. Increased release of immunoreactive cholecystokinin octapeptide by morphine and potentiation of mu-opioid analgesia by CCKB receptor antagonist L-365,260 in rat spinal cord.
Zhou Y; Sun YH; Zhang ZW; Han JS
Eur J Pharmacol; 1993 Apr; 234(2-3):147-54. PubMed ID: 8387008
[TBL] [Abstract][Full Text] [Related]
13. Spinal effect of the cholecystokinin-B receptor antagonist CI-988 on hyperalgesia, allodynia and morphine-induced analgesia in diabetic and mononeuropathic rats.
Coudoré-Civiale MA; Courteix C; Fialip J; Boucher M; Eschalier A
Pain; 2000 Oct; 88(1):15-22. PubMed ID: 11098095
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of morphine and clomipramine analgesia by cholecystokinin -B antagonist CI-988 in diabetic rats.
Coudoré-Civiale MA; Courteix C; Boucher M; Méen M; Fialip J; Eschalier A; Ardid D
Neurosci Lett; 2000 May; 286(1):37-40. PubMed ID: 10822147
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of intrathecally administered morphine and its interaction with cholecystokinin-B antagonist on thermal hyperalgesia following two models of experimental mononeuropathy in the rat.
Yamamoto T; Sakashita Y
Anesthesiology; 1999 May; 90(5):1382-91. PubMed ID: 10319787
[TBL] [Abstract][Full Text] [Related]
16. The effects of intrathecal galanin message-associated peptide (GMAP) on the flexor reflex in rats.
Xu XJ; Andell S; Hao JX; Wiesenfeld-Hallin Z; Bartfai T
Regul Pept; 1995 Jul; 58(1-2):19-24. PubMed ID: 8570856
[TBL] [Abstract][Full Text] [Related]
17. Intrathecal galanin at low doses increases spinal reflex excitability in rats more to thermal than mechanical stimuli.
Wiesenfeld-Hallin Z; Villar MJ; Hökfelt T
Exp Brain Res; 1988; 71(3):663-6. PubMed ID: 2458280
[TBL] [Abstract][Full Text] [Related]
18. A selective CCKB receptor antagonist potentiates, mu-, but not delta-opioid receptor-mediated antinociception in the formalin test.
Noble F; Blommaert A; Fournié-Zaluski MC; Roques BP
Eur J Pharmacol; 1995 Jan; 273(1-2):145-51. PubMed ID: 7737308
[TBL] [Abstract][Full Text] [Related]
19. The CCK-B receptor antagonist Cl 988 reverses tolerance to morphine in rats.
Hoffmann O; Wiesenfeld-Hallin Z
Neuroreport; 1994 Dec; 5(18):2565-8. PubMed ID: 7696605
[TBL] [Abstract][Full Text] [Related]
20. Galanin acts at GalR1 receptors in spinal antinociception: synergy with morphine and AP-5.
Hua XY; Hayes CS; Hofer A; Fitzsimmons B; Kilk K; Langel U; Bartfai T; Yaksh TL
J Pharmacol Exp Ther; 2004 Feb; 308(2):574-82. PubMed ID: 14610237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
